Proteomic Landscapes of Aging and Disease: Multi-Omics Integration, Machine Learning, and Translational Opportunities
- 1Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University, 507 Zhengmin Road, Shanghai 200433, China
- 2Department of Pathology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433, China
- 3Department of Anesthesiology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China
Abstract
Aging is accompanied by progressive changes in molecular, cellular, and systemic homeostasis. At the protein level, these changes involve altered proteostasis, post-translational regulation, and protein interaction networks, but their direction and functional significance vary by tissue, age, and disease context. Mass spectrometry, affinity-based assays, spatial proteomics, and emerging single-cell methods now support complementary views of proteins across tissues, biofluids, and cell populations. Integrating proteomics with genomic, transcriptomic, epigenomic, and metabolomic data can identify regulatory relationships that are not resolved by a single molecular layer; such integration prioritizes mechanisms but does not by itself establish causality. Machine-learning methods support spectral prediction, multi-omics integration, and prediction from high-dimensional protein profiles, although their performance depends on study design, calibration, and independent validation. This narrative review synthesizes protein alterations associated with aging and major age-related diseases, describes what multi-omics and computational methods add, compares emerging measurement technologies, and evaluates biomarker and therapeutic opportunities. Chronological-age prediction, estimation of biological aging, and prediction of clinical outcomes are treated as distinct objectives. Current evidence supports discovery and candidate prioritization; prospective clinical utility and causal therapeutic benefit remain to be established.
Related
- Proteomic and β-hydroxybutyrylation Landscapes Reveal AMPKα2-Associated Modulation in HUCMSC-Derived Exosome-Mediated Amelioration of Cardiac Aging
- Deciphering Cancer-Specific H3K27ac Landscapes Through Systematic Multi-Omics Integration and Development of Open-Access Genomic Annotation Platform
- HPV E6/E7, O-GlcNAcylation and mitochondrial remodeling in cervical cancer: mechanistic links and translational opportunities
- Network-based integration of cross-dataset proteomic profiles using fold-change directionality.
- Metabolic rewiring at the obesity-estrogen-polyamine axis in endometrial cancer: emerging mechanisms and translational opportunities.
BibTeX
@article{jin2026proteomic,
title = {{Proteomic Landscapes of Aging and Disease: Multi-Omics Integration, Machine Learning, and Translational Opportunities}},
author = {Xudong Jin and Xu Duan and Jinghao Ma and Zhaoze Wang and Weijie Chen and Huan Xu and Fujun Yang and Jian Chen},
journal = {International Journal of Molecular Sciences},
year = {2026},
month = nov,
doi = {10.3390/ijms272210057},
url = {https://www.mdpi.com/1422-0067/27/22/10057},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Proteomic Landscapes of Aging and Disease: Multi-Omics Integration, Machine Learning, and Translational Opportunities
AU - Xudong Jin
AU - Xu Duan
AU - Jinghao Ma
AU - Zhaoze Wang
AU - Weijie Chen
AU - Huan Xu
AU - Fujun Yang
AU - Jian Chen
PY - 2026
DA - 2026/11/10
JO - International Journal of Molecular Sciences
DO - 10.3390/ijms272210057
UR - https://www.mdpi.com/1422-0067/27/22/10057
AB - Aging is accompanied by progressive changes in molecular, cellular, and systemic homeostasis. At the protein level, these changes involve altered proteostasis, post-translational regulation, and protein interaction networks, but their direction and functional significance vary by tissue, age, and disease context. Mass spectrometry, affinity-based assays, spatial proteomics, and emerging single-cell methods now support complementary views of proteins across tissues, biofluids, and cell populations. Integrating proteomics with genomic, transcriptomic, epigenomic, and metabolomic data can identify regulatory relationships that are not resolved by a single molecular layer; such integration prioritizes mechanisms but does not by itself establish causality. Machine-learning methods support spectral prediction, multi-omics integration, and prediction from high-dimensional protein profiles, although their performance depends on study design, calibration, and independent validation. This narrative review synthesizes protein alterations associated with aging and major age-related diseases, describes what multi-omics and computational methods add, compares emerging measurement technologies, and evaluates biomarker and therapeutic opportunities. Chronological-age prediction, estimation of biological aging, and prediction of clinical outcomes are treated as distinct objectives. Current evidence supports discovery and candidate prioritization; prospective clinical utility and causal therapeutic benefit remain to be established.
SN - 1422-0067
ER -